Diabetologia

, Volume 57, Issue 5, pp 1084–1085

Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed? Reply to Lewis G and Maxwell AP [letter]

  • Peter W. G. Tennant
  • Svetlana V. Glinianaia
  • Rudy W. Bilous
  • Judith Rankin
  • Ruth Bell
Letter

DOI: 10.1007/s00125-014-3191-2

Cite this article as:
Tennant, P.W.G., Glinianaia, S.V., Bilous, R.W. et al. Diabetologia (2014) 57: 1084. doi:10.1007/s00125-014-3191-2

Keywords

ACE inhibitors Angiotensin II receptor antagonists HbA1c Hypertension Nephropathy Pregnancy 

Abbreviations

ACEI

ACE inhibitor

ARB

Angiotensin II receptor blocker

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Peter W. G. Tennant
    • 1
  • Svetlana V. Glinianaia
    • 1
  • Rudy W. Bilous
    • 2
    • 3
  • Judith Rankin
    • 1
    • 4
  • Ruth Bell
    • 1
    • 4
  1. 1.Institute of Health & SocietyNewcastle UniversityNewcastle upon TyneUK
  2. 2.Institute of Cellular MedicineNewcastle UniversityNewcastle upon TyneUK
  3. 3.James Cook University HospitalSouth Tees NHS TrustMiddlesbroughUK
  4. 4.Regional Maternity Survey OfficePublic Health EnglandNewcastle upon TyneUK

Personalised recommendations